Publication | Closed Access

Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices

Gastrointestinal BleedingHypertensionHeart FailureArteriovenous MalformationsCardiovascular DiseaseAntihypertensive TherapyCardiovascular PharmacologyVascular SurgeryVascular BiologyAngiotensin Ii AntagonismValvular Heart DiseasePublic HealthMedicineAtherosclerosisEmergency MedicineAnesthesiology